Large-scale mutational analysis of Kv11.1 reveals molecular insights into type 2 long QT syndrome

Corey L. Anderson; Catherine E. Kuzmicki; Ryan R. Childs; Caleb J. Hintz; Brian P. Delisle; Craig T. January

doi:10.1038/ncomms6535

Large-scale mutational analysis of Kv11.1 reveals molecular insights into type 2 long QT syndrome

Corey L. Anderson, Catherine E. Kuzmicki, Ryan R. Childs, Caleb J. Hintz, Brian P. Delisle, Craig T. January

Research output: Contribution to journal › Article › peer-review

103 Scopus citations

Abstract

It has been suggested that deficient protein trafficking to the cell membrane is the dominant mechanism associated with type 2 Long QT syndrome (LQT2) caused by Kv11.1 potassium channel missense mutations, and that for many mutations the trafficking defect can be corrected pharmacologically. However, this inference was based on expression of a small number of Kv11.1 mutations. We performed a comprehensive analysis of 167 LQT2-linked missense mutations in four Kv11.1 structural domains and found that deficient protein trafficking is the dominant mechanism for all domains except for the distal carboxy-terminus. Also, most pore mutations - in contrast to intracellular domain mutations - were found to have severe dominant-negative effects when co-expressed with wild-type subunits. Finally, pharmacological correction of the trafficking defect in homomeric mutant channels was possible for mutations within all structural domains. However, pharmacological correction is dramatically improved for pore mutants when co-expressed with wild-type subunits to form heteromeric channels.

Original language	English
Article number	5535
Journal	Nature Communications
Volume	5
DOIs	https://doi.org/10.1038/ncomms6535
State	Published - 2014

Bibliographical note

Funding Information:
We thank Dr Jennifer Poehls in the Dept. of Medicine and Dr Krishanu Saha in the Dept. of Biomedical Engineering at UW-Madison for helpful suggestions. We thank Dr Michael Ackerman (Mayo Clinic) for sharing pre-publication genotype information. This study was supported by the NIH R01 HL060723 (C.T.J.), an AHA Midwest Affiliate Predoctoral Fellowship (C.L.A.), a grant from the Saving tiny Hearts Society (B.P.D.) and a NIH training grant T32 HL07936 (Dr Jonathan C. Makielski).

Publisher Copyright:
© 2014 Macmillan Publishers Limited. All rights reserved.

ASJC Scopus subject areas

Chemistry (all)
Biochemistry, Genetics and Molecular Biology (all)
Physics and Astronomy (all)

Access to Document

10.1038/ncomms6535

Cite this

@article{69c2073125e04103a56d4d1180aa4c22,

title = "Large-scale mutational analysis of Kv11.1 reveals molecular insights into type 2 long QT syndrome",

abstract = "It has been suggested that deficient protein trafficking to the cell membrane is the dominant mechanism associated with type 2 Long QT syndrome (LQT2) caused by Kv11.1 potassium channel missense mutations, and that for many mutations the trafficking defect can be corrected pharmacologically. However, this inference was based on expression of a small number of Kv11.1 mutations. We performed a comprehensive analysis of 167 LQT2-linked missense mutations in four Kv11.1 structural domains and found that deficient protein trafficking is the dominant mechanism for all domains except for the distal carboxy-terminus. Also, most pore mutations - in contrast to intracellular domain mutations - were found to have severe dominant-negative effects when co-expressed with wild-type subunits. Finally, pharmacological correction of the trafficking defect in homomeric mutant channels was possible for mutations within all structural domains. However, pharmacological correction is dramatically improved for pore mutants when co-expressed with wild-type subunits to form heteromeric channels.",

author = "Anderson, {Corey L.} and Kuzmicki, {Catherine E.} and Childs, {Ryan R.} and Hintz, {Caleb J.} and Delisle, {Brian P.} and January, {Craig T.}",

note = "Funding Information: We thank Dr Jennifer Poehls in the Dept. of Medicine and Dr Krishanu Saha in the Dept. of Biomedical Engineering at UW-Madison for helpful suggestions. We thank Dr Michael Ackerman (Mayo Clinic) for sharing pre-publication genotype information. This study was supported by the NIH R01 HL060723 (C.T.J.), an AHA Midwest Affiliate Predoctoral Fellowship (C.L.A.), a grant from the Saving tiny Hearts Society (B.P.D.) and a NIH training grant T32 HL07936 (Dr Jonathan C. Makielski). Publisher Copyright: {\textcopyright} 2014 Macmillan Publishers Limited. All rights reserved.",

year = "2014",

doi = "10.1038/ncomms6535",

language = "English",

volume = "5",

}

TY - JOUR

T1 - Large-scale mutational analysis of Kv11.1 reveals molecular insights into type 2 long QT syndrome

AU - Anderson, Corey L.

AU - Kuzmicki, Catherine E.

AU - Childs, Ryan R.

AU - Hintz, Caleb J.

AU - Delisle, Brian P.

AU - January, Craig T.

N1 - Funding Information: We thank Dr Jennifer Poehls in the Dept. of Medicine and Dr Krishanu Saha in the Dept. of Biomedical Engineering at UW-Madison for helpful suggestions. We thank Dr Michael Ackerman (Mayo Clinic) for sharing pre-publication genotype information. This study was supported by the NIH R01 HL060723 (C.T.J.), an AHA Midwest Affiliate Predoctoral Fellowship (C.L.A.), a grant from the Saving tiny Hearts Society (B.P.D.) and a NIH training grant T32 HL07936 (Dr Jonathan C. Makielski). Publisher Copyright: © 2014 Macmillan Publishers Limited. All rights reserved.

PY - 2014

Y1 - 2014

N2 - It has been suggested that deficient protein trafficking to the cell membrane is the dominant mechanism associated with type 2 Long QT syndrome (LQT2) caused by Kv11.1 potassium channel missense mutations, and that for many mutations the trafficking defect can be corrected pharmacologically. However, this inference was based on expression of a small number of Kv11.1 mutations. We performed a comprehensive analysis of 167 LQT2-linked missense mutations in four Kv11.1 structural domains and found that deficient protein trafficking is the dominant mechanism for all domains except for the distal carboxy-terminus. Also, most pore mutations - in contrast to intracellular domain mutations - were found to have severe dominant-negative effects when co-expressed with wild-type subunits. Finally, pharmacological correction of the trafficking defect in homomeric mutant channels was possible for mutations within all structural domains. However, pharmacological correction is dramatically improved for pore mutants when co-expressed with wild-type subunits to form heteromeric channels.

AB - It has been suggested that deficient protein trafficking to the cell membrane is the dominant mechanism associated with type 2 Long QT syndrome (LQT2) caused by Kv11.1 potassium channel missense mutations, and that for many mutations the trafficking defect can be corrected pharmacologically. However, this inference was based on expression of a small number of Kv11.1 mutations. We performed a comprehensive analysis of 167 LQT2-linked missense mutations in four Kv11.1 structural domains and found that deficient protein trafficking is the dominant mechanism for all domains except for the distal carboxy-terminus. Also, most pore mutations - in contrast to intracellular domain mutations - were found to have severe dominant-negative effects when co-expressed with wild-type subunits. Finally, pharmacological correction of the trafficking defect in homomeric mutant channels was possible for mutations within all structural domains. However, pharmacological correction is dramatically improved for pore mutants when co-expressed with wild-type subunits to form heteromeric channels.

UR - http://www.scopus.com/inward/record.url?scp=84923313308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923313308&partnerID=8YFLogxK

U2 - 10.1038/ncomms6535

DO - 10.1038/ncomms6535

M3 - Article

C2 - 25417810

AN - SCOPUS:84923313308

VL - 5

M1 - 5535

ER -

Large-scale mutational analysis of Kv11.1 reveals molecular insights into type 2 long QT syndrome

Abstract

Bibliographical note

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this